FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386944723> ?p ?o ?g. }

• W4386944723 abstract "To investigate the use of comprehensive pre-treatment staging with multiple diagnostic modalities, including functional imaging and minimally invasive surgical procedures, in locally advanced pancreatic cancer (LAPC) patients. The primary objective was to detect occult metastatic disease using staging laparoscopy and 18FFDG-PET/CT scan. The study also evaluated treatment efficacy and outcomes in LAPC patients treated with combined therapies.This study was a secondary analysis of three prospective studies of chemoradiotherapy (CRT) with or without induction chemotherapy (IC). The inclusion period was from December 2009 until February 2023. An intensified pretreatment staging was conducted for all LAPC patients. Patients without distant disease at initial staging, with borderline resectable or unresectable LAPC, were enrolled in chemoradiotherapy combination protocols (CRT with or without IC). IC regimens included GemOx or FOLFIRINOX for four cycles, followed by concurrent CRT with gemcitabine. The primary endpoint was the detection of occult metastatic disease, and secondary objectives included resection rate, treatment toxicity, overall survival (OS), progression-free survival (PFS), local control (LC), and metastasis-free survival (MFS).Out of the 134 LAPC patients, 33.5% were identified with metastatic disease. Of these, 23.1% had a positive exploratory laparoscopy. Additionally, 13.4% were identified as having distant metastases by 18-FDG PET/CT. The median PFS for all patients who completed CRT was 14.3 months, and the median OS was 17.2 months. Resected patients after the combined therapies demonstrated significantly improved outcomes compared to non-resected patients (median PFS, 22.5 mo vs. 9.5 mo, P<0.001; median OS, 38.2 mo vs. 13 mo, P<0.001). Moreover, patients treated with IC followed by CRT showed significantly better outcomes compared to upfront CRT group (median PFS, 19 mo vs. 9.9 mo, P<0.001; median OS, 19.3 mo vs. 14.6 mo, P<0.001). At univariate logistic regression analysis, the adding of IC was the only predictor for resection rate (95% CI 0.12-1.02, P=0.05), and this data was confirmed at multivariate analysis (95% CI 0.09-0.98, P=0.04). Haematological and gastrointestinal toxicities were observed during treatment, with manageable adverse events.The use of comprehensive pre-treatment staging, including laparoscopy and 18F-FDG-PET/CT scan, is an effective approach in identifying occult metastatic disease in LAPC patients. Our findings offer valuable insights into accurate staging and treatment efficacy, providing evidence-based support for optimal management strategies in LAPC patients." @default.
• W4386944723 created "2023-09-23" @default.
• W4386944723 creator A5003302348 @default.
• W4386944723 creator A5005999785 @default.
• W4386944723 creator A5019046789 @default.
• W4386944723 creator A5020106424 @default.
• W4386944723 creator A5034569772 @default.
• W4386944723 creator A5039880019 @default.
• W4386944723 creator A5046611680 @default.
• W4386944723 creator A5057394271 @default.
• W4386944723 creator A5060064110 @default.
• W4386944723 creator A5061605763 @default.
• W4386944723 creator A5063528629 @default.
• W4386944723 creator A5071083564 @default.
• W4386944723 creator A5074717064 @default.
• W4386944723 creator A5077246272 @default.
• W4386944723 creator A5079046921 @default.
• W4386944723 creator A5087477011 @default.
• W4386944723 date "2023-09-22" @default.
• W4386944723 modified "2023-10-03" @default.
• W4386944723 title "The impact of intensified staging and combined therapies in locally advanced pancreatic cancer: a secondary analysis of prospective studies" @default.
• W4386944723 doi "https://doi.org/10.1097/js9.0000000000000755" @default.
• W4386944723 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37737898" @default.
• W4386944723 hasPublicationYear "2023" @default.
• W4386944723 type Work @default.
• W4386944723 citedByCount "0" @default.
• W4386944723 crossrefType "journal-article" @default.
• W4386944723 hasAuthorship W4386944723A5003302348 @default.
• W4386944723 hasAuthorship W4386944723A5005999785 @default.
• W4386944723 hasAuthorship W4386944723A5019046789 @default.
• W4386944723 hasAuthorship W4386944723A5020106424 @default.
• W4386944723 hasAuthorship W4386944723A5034569772 @default.
• W4386944723 hasAuthorship W4386944723A5039880019 @default.
• W4386944723 hasAuthorship W4386944723A5046611680 @default.
• W4386944723 hasAuthorship W4386944723A5057394271 @default.
• W4386944723 hasAuthorship W4386944723A5060064110 @default.
• W4386944723 hasAuthorship W4386944723A5061605763 @default.
• W4386944723 hasAuthorship W4386944723A5063528629 @default.
• W4386944723 hasAuthorship W4386944723A5071083564 @default.
• W4386944723 hasAuthorship W4386944723A5074717064 @default.
• W4386944723 hasAuthorship W4386944723A5077246272 @default.
• W4386944723 hasAuthorship W4386944723A5079046921 @default.
• W4386944723 hasAuthorship W4386944723A5087477011 @default.
• W4386944723 hasBestOaLocation W43869447231 @default.
• W4386944723 hasConcept C121608353 @default.
• W4386944723 hasConcept C126322002 @default.
• W4386944723 hasConcept C126838900 @default.
• W4386944723 hasConcept C141071460 @default.
• W4386944723 hasConcept C143998085 @default.
• W4386944723 hasConcept C203092338 @default.
• W4386944723 hasConcept C2776611710 @default.
• W4386944723 hasConcept C2776694085 @default.
• W4386944723 hasConcept C2777148230 @default.
• W4386944723 hasConcept C2778424827 @default.
• W4386944723 hasConcept C2778822529 @default.
• W4386944723 hasConcept C2779984678 @default.
• W4386944723 hasConcept C2780210213 @default.
• W4386944723 hasConcept C2780258809 @default.
• W4386944723 hasConcept C2780962732 @default.
• W4386944723 hasConcept C526805850 @default.
• W4386944723 hasConcept C535046627 @default.
• W4386944723 hasConcept C71924100 @default.
• W4386944723 hasConceptScore W4386944723C121608353 @default.
• W4386944723 hasConceptScore W4386944723C126322002 @default.
• W4386944723 hasConceptScore W4386944723C126838900 @default.
• W4386944723 hasConceptScore W4386944723C141071460 @default.
• W4386944723 hasConceptScore W4386944723C143998085 @default.
• W4386944723 hasConceptScore W4386944723C203092338 @default.
• W4386944723 hasConceptScore W4386944723C2776611710 @default.
• W4386944723 hasConceptScore W4386944723C2776694085 @default.
• W4386944723 hasConceptScore W4386944723C2777148230 @default.
• W4386944723 hasConceptScore W4386944723C2778424827 @default.
• W4386944723 hasConceptScore W4386944723C2778822529 @default.
• W4386944723 hasConceptScore W4386944723C2779984678 @default.
• W4386944723 hasConceptScore W4386944723C2780210213 @default.
• W4386944723 hasConceptScore W4386944723C2780258809 @default.
• W4386944723 hasConceptScore W4386944723C2780962732 @default.
• W4386944723 hasConceptScore W4386944723C526805850 @default.
• W4386944723 hasConceptScore W4386944723C535046627 @default.
• W4386944723 hasConceptScore W4386944723C71924100 @default.
• W4386944723 hasLocation W43869447231 @default.
• W4386944723 hasLocation W43869447232 @default.
• W4386944723 hasOpenAccess W4386944723 @default.
• W4386944723 hasPrimaryLocation W43869447231 @default.
• W4386944723 hasRelatedWork W1864593475 @default.
• W4386944723 hasRelatedWork W1883657005 @default.
• W4386944723 hasRelatedWork W2038539285 @default.
• W4386944723 hasRelatedWork W2114645101 @default.
• W4386944723 hasRelatedWork W2409809131 @default.
• W4386944723 hasRelatedWork W284685154 @default.
• W4386944723 hasRelatedWork W2953569012 @default.
• W4386944723 hasRelatedWork W3029737226 @default.
• W4386944723 hasRelatedWork W3154040450 @default.
• W4386944723 hasRelatedWork W3196960728 @default.
• W4386944723 isParatext "false" @default.
• W4386944723 isRetracted "false" @default.
• W4386944723 workType "article" @default.